NDC 65162-960
Levomilnacipran
Levomilnacipran
Levomilnacipran is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Llc. The primary component is Levomilnacipran Hydrochloride.
| Product ID | 65162-960_32f4b2b4-c912-43a2-8c5b-e370352b980d |
| NDC | 65162-960 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Levomilnacipran |
| Generic Name | Levomilnacipran |
| Dosage Form | Capsule, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-02-04 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA210790 |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Substance Name | LEVOMILNACIPRAN HYDROCHLORIDE |
| Active Ingredient Strength | 40 mg/1 |
| Pharm Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |